Prevalence and risk factors of functional abdominal disorders according to a survey study among young people
https://doi.org/10.21518/ms2024-193
Abstract
Introduction. The etiological aspects of functional dyspepsia (FD) and irritable bowel syndrome (IBS) are not clear; the epidemiology of diseases in age groups and societies can help in understanding the starting causes of the pathology.
Aim. To assess the risk factors for the development and prevalence of abdominal symptoms characteristic of FD and IBS among active users of Internet communities.
Materials and methods. An anonymous online survey was conducted among medical university students. The questionnaire contains questions about complaints typical of FD and IBS over the past week, “alarm” symptoms, personal characteristics of the respondent and possible risk factors: smoking, family history, taking antibiotics, iron pills, non-steroidal anti-inflammatory drugs (NSAIDs).
Results and discussion. The study included 983 respondents aged 18−26 years, 279 men and 704 women. Symptoms of unstudied regular (>1 time per week) postprandial dyspeptic disorders, bloating and abdominal pain were identified in 391 (39.8%) people, of which 29% were men and 44% were women (p < 0.001). Risk factors for regular unstudied disorders were having relatives with chronic gastrointestinal diseases (OR 2.05 [1.56, 2.70]); female gender (OR 1.92 [1.43, 2.59]); taking NSAIDs (OR 1.48 [1.14; 1.91]); for women – smoking (OR 2.24 [1.57; 3.18]). 6.5% of respondents met the criteria for FD, of which 23.4% had isolated epigastric pain, 26.6% had isolated postprandial distress syndrome, and 50% had combined FD. 2.5% of respondents met the criteria for IBS, 64% of whom had overlap syndrome with FD. The presence of FD was associated with NSAIDs use: r = 0.081; p = 0.011 (OR 1.95 [1.16; 3.30]).
Conclusions. The prevalence of FD and/or IBS among people aged 18−26 years is 7.4%, with no significant differences between men and women. Taking NSAIDs can be considered as a factor contributing to the development of FD.
About the Author
T. V. Zhestkova
Ryazan State Medical University
Russian Federation
Russian Federation
Tatyana V. Zhestkova, Cand. Sci. (Med.), Associate Professor of the Department of Propaedeutic Internal Diseases,
9, Vysokovoltnaya St., Ryazan, 390026
References
1. Ivashkin VT, Maev IV, Shelygin YuA, Baranskaya EK, Belous SS, Belousova EA et al. Diagnosis and treatment of irritable bowel syndrome: clinical recommendations of the Russian gastroenterological association and association of coloproctologists of Russia. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2021;31(5):74–95. (In Russ.) https://doi.org/10.22416/1382-4376-2021-31-5-74-95.
2. Ivashkin VT, Mayev IV, Sheptulin AA, Lapina TL, Trukhmanov AS, Kartavenko IM et al. Diagnosis and treatment of the functional dyspepsia: clinical guidelines of the Russian Gastroenterological Association. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2017;27(1):50–61. (In Russ.) https://doi.org/10.22416/1382-4376-2017-27-1-50-61.
3. Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J et al. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology. 2021;160(1):99–114.e3. https://doi.org/10.1053/j.gastro.2020.04.014.
4. Lazebnik LB, Golovanova EV, Volel BA, Korochanskaya NV, Lyalyukova EA, Mokshina MV et al. Functional gastrointestinal disorders. Overlap syndrome. Clinical guidelines of the Russian Scientific Medical Society of Internal Medicine and Gastroenterological Scientific Society of Russia. Experimental and Clinical Gastroenterology. 2021;192(8):5–117. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-192-8-5-117.
5. Black CJ, Ford AC. Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nat Rev Gastroenterol Hepatol. 2020;17(8):473–486. https://doi.org/10.1038/s41575-020-0286-8.
6. Burns GL, Hoedt EC, Walker MM, Talley NJ, Keely S. Physiological mechanisms of unexplained (functional) gastrointestinal disorders. J Physiol. 2021;599(23):5141–5161. https://doi.org/10.1113/JP281620.
7. Kumagai H, Yokoyama K, Imagawa T, Yamagata T. Functional dyspepsia and irritable bowel syndrome in teenagers: Internet survey. Pediatr Int. 2016;58(8):714–720. https://doi.org/10.1111/ped.12884.
8. Korneenkov AA, Ovchinnikov PA, Vyazemskaya EE, Dvoryanchikov VV, Ryazantsev SV, Yanov YuK, Fanta IV. Assessment of working conditions and risks caused by the COVID-19 pandemic: results of an online survey of personnel of medical organizations. Meditsinskiy Sovet. 2023;17(7):160–169. (In Russ.) https://doi.org/10.21518/ms2023-071.
9. Devrishov PD, Kolomin VV, Filyaev VN, Kudryasheva IA. Hygienic aspects of influence of environmental factors on formation of schoolchildren’s health. I.P. Pavlov Russian Medical Biological Herald. 2019;27(4):530–535. (In Russ.) https://doi.org/10.23888/PAVLOVJ2019274530-535.
10. Ivashkin VT, Sheptulin A, Shifrin O, Poluektova E, Pavlov C, Ivashkin K et al. Clinical validation of the “7 × 7” questionnaire for patients with functional gastrointestinal disorders. J Gastroenterol Hepatol. 2019;34(6):1042–1048. https://doi.org/10.1111/jgh.14546.
11. Barberio B, Mahadeva S, Black CJ, Savarino EV, Ford AC. Systematic review with meta-analysis: global prevalence of uninvestigated dyspepsia according to the Rome criteria. Aliment Pharmacol Ther. 2020;52(5):762–773. https://doi.org/10.1111/apt.16006.
12. Ford AC, Marwaha A, Sood R, Moayyedi P. Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Gut. 2015;64(7):1049–1057. https://doi.org/10.1136/gutjnl-2014-307843.
13. Tsukanov VV, Vasyutin AV, Tonkikh YuL. Prevalence, risk factors, and ethnic characteristics of uninvestigated dyspepsia. RMJ. Medical Review. 2020;4(5):264–267. (In Russ.) https://doi.org/10.32364/2587-6821-2020-4-5-263-267.
14. Arnaout AY, Alhejazi TJ, Nerabani Y, Hamdan O, Arnaout K, Arnaout I et al. The prevalence and risk factors of functional dyspepsia among adults in low- and middle-income countries: An international cross-sectional study. Medicine (Baltimore). 2023;102(40):e35437. https://doi.org/10.1097/MD.0000000000035437.
15. Kim SE, Kim N, Lee JY, Park KS, Shin JE, Nam K et al. Prevalence and Risk Factors of Functional Dyspepsia in Health Check-up Population: A Nationwide Multicenter Prospective Study. J Neurogastroenterol Motil. 2018;24(4):603–613. https://doi.org/10.5056/jnm18068.
16. Bharucha AE, Sharma M. Painful and Painless Constipation: All Roads Lead to (A Change in) Rome. Dig Dis Sci. 2018;63(7):1671–1674. https://doi.org/10.1007/s10620-018-5027-2.
17. Filippov EV, Zaikina EV, Nikylina NN. Is existence of clinically significant anxiety and depression a new risk factor for chronic non-infectious diseases? Science of the Young (Eruditio Juvenium). 2019;7(1):28–37. (In Russ.) https://doi.org/10.23888/HMJ20197128-37.
18. Zia JK, Lenhart A, Yang PL, Heitkemper MM, Baker J, Keefer L et al. Risk Factors for Abdominal Pain-Related Disorders of Gut-Brain Interaction in Adults and Children: A Systematic Review. Gastroenterology. 2022;163(4):995–1023.e3. https://doi.org/10.1053/j.gastro.2022.06.028.
19. Narayanan SP, Anderson B, Bharucha AE. Sex- and Gender-Related Differences in Common Functional Gastroenterologic Disorders. Mayo Clin Proc. 2021;96(4):1071–1089. https://doi.org/10.1016/j.mayocp.2020.10.004.
20. Zand Irani M, Jones MP, Halland M, Herrick L, Choung RS, Saito Loftus YA et al. Prevalence, symptoms and risk factor profile of rumination syndrome and functional dyspepsia: a population-based study. Aliment Pharmacol Ther. 2021;54(11-12):1416–1431. https://doi.org/10.1111/apt.16630.
21. Javed M, Yadav T, Shakil J, Haider Zaidi ST, Zehra M. Prevalence of irritable bowel syndrome and functional dyspepsia and their relationship with generalized anxiety disorder among medical students in Karachi. J Pak Med Assoc. 2022;72(10):2132–2136. https://doi.org/10.47391/JPMA.4927.
22. Beh KH, Chuah KH, Rappek NAM, Mahadeva S. The association of body mass index with functional dyspepsia is independent of psychological morbidity: A cross-sectional study. PLoS ONE. 2021;16(1):e0245511. https://doi.org/10.1371/journal.pone.0245511.
23. Feinle-Bisset C. Upper gastrointestinal sensitivity to meal-related signals in adult humans – relevance to appetite regulation and gut symptoms in health, obesity and functional dyspepsia. Physiol Behav. 2016;162:69–82. https://doi.org/10.1016/j.physbeh.2016.03.021.
24. Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(10):908–917. https://doi.org/10.1016/S2468-1253(20)30217-X.
25. Accarie A, Toth J, Wauters L, Farré R, Tack J, Vanuytsel T. Estrogens Play a Critical Role in Stress-Related Gastrointestinal Dysfunction in a Spontaneous Model of Disorders of Gut-Brain Interaction. Cells. 2022;11(7):1214. https://doi.org/10.3390/cells11071214.
26. Choi YJ, Park YS, Kim N, Kim YS, Lee SM, Lee DH, Jung HC. Gender differences in ghrelin, nociception genes, psychological factors and quality of life in functional dyspepsia. World J Gastroenterol. 2017;23(45):8053–8061. https://doi.org/10.3748/wjg.v23.i45.8053.
27. Maev IV, Okhlobystina OZ, Khalif IL, Andreev DN. Irritable bowel syndrome in the Russian Federation: results of the ROMERUS multicenter observational study. Terapevticheskii Arkhiv. 2023;95(1):38–51. (In Russ.) https://doi.org/10.26442/00403660.2023.01.202043.
28. Yap PR, Goh KL. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Induced Dyspepsia. Curr Pharm Des. 2015;21(35):5073–5081. https://doi.org/10.2174/1381612821666150915105738.
29. Simanenkov VI, Maev IV, Tkacheva ON, Alekseenko SA, Andreev DN, Bordin DS et al. Syndrome of increased epithelial permeability in clinical practice. Multidisciplinary national Consensus. Cardiovascular Therapy and Prevention. 2021;20(1):2758. (In Russ.) https://doi.org/10.15829/1728-8800-2021-2758.
30. von Wulffen M, Talley NJ, Hammer J, McMaster J, Rich G, Shah A et al. Overlap of Irritable Bowel Syndrome and Functional Dyspepsia in the Clinical Setting: Prevalence and Risk Factors. Dig Dis Sci. 2019;64(2):480–486. https://doi.org/10.1007/s10620-018-5343-6.
Review
For citations:
Zhestkova TV. Prevalence and risk factors of functional abdominal disorders according to a survey study among young people. Meditsinskiy sovet = Medical Council. 2024;(8):12-18. (In Russ.) https://doi.org/10.21518/ms2024-193
Views:
189
Email this article 